News

Zelluna Immunotherapy and Glycostem Therapeutics announce partnership to develop allogeneic TCR-NK therapies

19 November 2019

Pepscan doubles GMP production capacity to facilitate clients’ growth

10 October 2019

Glycostem raises capital for phase I/IIa clinical trials

Clinical peptides for innovative personalized cancer vaccine trial

Glycostem enters into strategic Asian collaboration